Cargando…

The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2

BACKGROUND: To explore the expression pattern and role of the novel long non-coding RNA LATS2 antisense transcript 1 (LATS2-AS1-001) in gastric cancer (GC). METHODS: qRT-PCR was applied to evaluate LATS2-AS1-001 expression and correlation with LATS2 in GC. In vitro experiments were performed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Dan, Wang, Ying, Wang, Huan, Xin, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260745/ https://www.ncbi.nlm.nih.gov/pubmed/32514249 http://dx.doi.org/10.1186/s12935-020-01285-w

Ejemplares similares

Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2022)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer
por: Ma, Li-cong, et al.
Publicado: (2020)

Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
por: Darbankhales, Soroush, et al.
Publicado: (2020)

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
por: Furth, Noa, et al.
Publicado: (2018)

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016)

NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling
por: Yin, Lei, et al.
Publicado: (2019)

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)

Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
por: Hong, Seong Hwi, et al.
Publicado: (2023)

β-Arrestin 2 suppresses the activation of YAP by promoting LATS kinase activity
por: Kim, Minsuh, et al.
Publicado: (2022)

The TGF(β)→TAK1→LATS→YAP1 Pathway Regulates the Spatiotemporal Dynamics of YAP1
por: Kim, Min-Kyu, et al.
Publicado: (2023)

Calotropin activates YAP through downregulation of LATS1 in colorectal cancer cells
por: Zhou, Limin, et al.
Publicado: (2019)

RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
por: Pan, Yi, et al.
Publicado: (2018)

Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML)
por: Feng, Yubin, et al.
Publicado: (2020)

WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein
por: Zou, Jianping, et al.
Publicado: (2023)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma
por: Liu, Ke, et al.
Publicado: (2020)

Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer
por: Shi, Xuefei, et al.
Publicado: (2018)

LATS1 and LATS2 Phosphorylate CDC26 to Modulate Assembly of the Tetratricopeptide Repeat Subcomplex of APC/C
por: Masuda, Kenta, et al.
Publicado: (2015)

Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate
por: Abou Nader, Nour, et al.
Publicado: (2022)

S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway
por: Tao, Yi-Ping, et al.
Publicado: (2023)

The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2
por: Kantipudi, Satish, et al.
Publicado: (2020)

NRP1 transduces mechanical stress inhibition via LATS1/YAP in hypertrophic scars
por: Li, Mengzhi, et al.
Publicado: (2023)

Role of a novel mouse mutant of the Galnt2(tm1Lat/tm1Lat) gene in otitis media
por: Ma, Weijun, et al.
Publicado: (2023)

Correction: LATS1 and LATS2 Phosphorylate CDC26 to Modulate Assembly of the Tetratricopeptide Repeat Subcomplex of APC/C
por: Masuda, Kenta, et al.
Publicado: (2015)

An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2
por: Park, Gun-Soo, et al.
Publicado: (2016)

Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020)

Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
por: Ji, Tianhai, et al.
Publicado: (2012)

Pharmacological Activation of YAP/TAZ by Targeting LATS1/2 Enhances Periodontal Tissue Regeneration in a Murine Model
por: Sato, Akiko, et al.
Publicado: (2023)

Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer
por: Jin, Longyang, et al.
Publicado: (2018)

Corrigendum: Role of a novel mouse mutant of the Galnt2(tm1Lat/tm1Lat) gene in otitis media
por: Ma, Weijun, et al.
Publicado: (2023)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells
por: Song, Wei, et al.
Publicado: (2019)

Irisin Ameliorates Intervertebral Disc Degeneration by Activating LATS/YAP/CTGF Signaling
por: Chen, Taiqiu, et al.
Publicado: (2022)

WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice
por: Park, Jaeoh, et al.
Publicado: (2020)

LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK–Mfn2 signaling pathway
por: Song, Jie, et al.
Publicado: (2019)

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway
por: Wang, Chien-Hao, et al.
Publicado: (2023)

Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells
por: Li, W, et al.
Publicado: (2016)

Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade
por: Lodge, Emily J, et al.
Publicado: (2019)

Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer
por: Yu, Tian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_72h9hfv0cv3vt01ut93hhf0tpv